Class 2 recall-Pemetrexed 100mg/1100mg Infusion bag

Sun Pharmaceutical Industries Europe B.V. is recalling the listed batches as a precautionary measure due to visible particulate matter during stability testing.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sun-pharma-uk-limited-pemetrexed-1000mg-slash-100ml-10mg-slash-ml-and-1100mg-slash-100ml-11mg-slash-ml-infusion-bag-el-24-a-slash-29?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=072b40d3-df8c-47dd-a6b7-6c15a2e30f34&utm_content=immediately

Further Information

For medical information enquiries please contact, medinfoeurope@sunpharma.com.

For stock control enquiries please contact Sun Pharma Customer Service, Cserv.uk@sunpharma.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Gemcitabine PPF 1800mg/180mL Infusion; Gemcitabine PPF 1600mg/160mL Infusion; Irinotecan PPF 360mg/240mL Infusion

Sun Pharma UK Ltd is recalling certain batches as a precautionary measure due to a small number of leaks found intermittently in the infusion bags.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-sun-pharma-uk-limited-gemcitabine-ppf-1800mg-slash-180ml-infusion-gemcitabine-ppf-1600mg-slash-160ml-infusion-irinotecan-ppf-360mg-slash-240ml-infusion-el-24-a-slash-28?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=d2d18634-9729-4c08-ab73-4f5410162e11&utm_content=immediately

Further Information

For medical information enquiries please contact, medinfoeurope@sunpharma.com.

For stock control enquiries please contact Sun Pharma Customer Service, Cserv.uk@sunpharma.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Propantheline Tablets 15mg (Genesis Pharmaceuticals livery)

Chelonia Healthcare Limited has informed the MHRA that an error relating to the product description was identified in the Patient Information Leaflet (PIL) for the batches listed in this notification.

MHRA Drug alert date: 9th July 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-chelonia-healthcare-limited-propantheline-tablets-15mg-genesis-pharmaceuticals-livery-el-24-a-slash-27?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f28f044e-ba2e-41cd-8103-d934702d907b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For stock control queries please contact info@genesis-pharma.com (Tel 020 7201 0400)

For Medical queries please contact eupvg@genreg.eu (Tel: 020 7201 0421).

Class 2 recall-Itraconazole 10mg/ml Oral Solution

Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals.

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-kent-pharma-uk-itraconazole-10mg-slash-ml-oral-solution-el-24-a-slash-26?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f48bd582-6f15-4f98-9b73-467a2563cd4e&utm_content=immediately

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.services@kent-athlone.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Atomoxetine capsules (all strengths, Accord livery)

Accord Healthcare Ltd is recalling various batches after retesting showed out of specification results. The tabled batches are being recalled as a precautionary measure after testing showed variability of the capsule contents beyond permitted levels.

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-accord-healthcare-ltd-atomoxetine-10mg-18mg-25mg-40mg-60mg-80mg-100mg-hard-capsules-el-24-a-slash-25?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=15af204d-8a5a-40bb-91f9-12e8776e19d9&utm_content=immediately

Further Information

For medical information enquiries please contact Accord-UK Ltd Medical Information Department on 01271 385257

For stock control enquiries please contact Accord- UK Ltd Customer Services Team on 0800 373573. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Class 4 caution in use-Grepid 75mg tablets

PHARMATHEN S.A. has informed the MHRA that the outer carton (box) of some batches of Grepid 75mg film coated tablets is missing the medicines legal classification for a Prescription Only Medicine ‘POM.’ This notification contains additional batches impacted by this issue.

MHRA Drug alert date: 24th June 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-pharmathen-s-dot-a-grepid-75-mg-film-coated-tablets-kent-pharma-livery-el-24-a-slash-24?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f15adf5b-de21-4835-8382-afc63f6af7a2&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For more information, medical or supply enquiries, please contact telephone: +30 210 6604300 or via email: pharmacovigilance@pharmathen.com & info@pharmathen.com

Class 3 recall-GoResp Digihaler

Teva UK Limited has informed the MHRA that it plans to withdraw from further sale all batches of GoResp Digihaler (budesonide and formoterol fumarate dihydrate) and the linked Digihaler App for commercial reasons.

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-teva-uk-limited-goresp-digihaler-el-24-a-slash-23?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=9edb0dde-bbc2-4ee4-8039-9d803a602c9c&utm_content=immediately

Further Information

For medical information, please contact medinfo@tevauk.com (Tel. 02075 407117) and stock control enquiries please contact customer.services@tevauk.com (Tel. 0800 590502).

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Class 4 Caution in use- Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets

Viatris UK Healthcare Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in the specified batches of Oxcarbazepine 150 mg, 300 mg & 600 mg Film-Coated Tablets do not contain the most up to date safety information.

MHRA Drug alert date: 17th June 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-viatris-uk-healthcare-ltd-oxcarbazepine-mylan-150-mg-300mg-600mg-film-coated-tablets-el-24-a-slash-22

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control queries please contact:

Viatris UK Healthcare Limited Medical Information at +44 (0)1707 853 000 (select option 1) or info.uk@viatris.com. Customer Services can be reached at +44 (0)1707 853 000 (select option 2).

Field Safety notice-Tegaderm - Transparent Film Dressing Frame Style

We have received a recall notice from 3M regarding two batches of Tegaderm Transparent film dressings

Date of recall: 31/05/24

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Paracetamol 500mg, 1000mg Film-Coated Tablets Drugs R Us

Dawa Limited has informed the MHRA that specified batches listed in this notification have been packed with an outdated Patient Information Leaflet (PIL).

MHRA Drug alert date: 10th June 2024

MHRA drug alert link  https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-dawa-limited-paracetamol-500mg-1000mg-film-coated-tablets-el-24-a-slash-21

This is a caution in use only we are not accepting stock returns

Further Information

For more information, medical information and stock control queries please contact Drugsrus Limited (distributor) on 020 8423 3800 or email info@drugsrus.co.uk.